ALEVE-D SINUS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aleve-d Sinus, and what generic alternatives are available?
Aleve-d Sinus is a drug marketed by Bayer and is included in one NDA.
The generic ingredient in ALEVE-D SINUS is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aleve-d Sinus
A generic version of ALEVE-D SINUS was approved as naproxen sodium; pseudoephedrine hydrochloride by PERRIGO on March 17th, 2004.
US Patents and Regulatory Information for ALEVE-D SINUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer | ALEVE-D SINUS & COLD | naproxen sodium; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021076-001 | Nov 29, 1999 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
